nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—CYP2C19—Methimazole—Graves' disease	0.198	0.25	CbGbCtD
Olanzapine—CYP1A2—Methimazole—Graves' disease	0.183	0.231	CbGbCtD
Olanzapine—CYP2C9—Methimazole—Graves' disease	0.165	0.208	CbGbCtD
Olanzapine—CYP2D6—Methimazole—Graves' disease	0.151	0.19	CbGbCtD
Olanzapine—CYP3A4—Methimazole—Graves' disease	0.0958	0.121	CbGbCtD
Olanzapine—DRD5—eyelid—Graves' disease	0.0361	0.375	CbGeAlD
Olanzapine—FMO3—eye—Graves' disease	0.00424	0.0441	CbGeAlD
Olanzapine—CHRM5—eye—Graves' disease	0.00361	0.0375	CbGeAlD
Olanzapine—FMO3—pituitary gland—Graves' disease	0.00315	0.0327	CbGeAlD
Olanzapine—FMO3—adipose tissue—Graves' disease	0.00314	0.0326	CbGeAlD
Olanzapine—H1F0—connective tissue—Graves' disease	0.003	0.0311	CbGeAlD
Olanzapine—FMO3—thyroid gland—Graves' disease	0.00272	0.0282	CbGeAlD
Olanzapine—HTR1D—eye—Graves' disease	0.00241	0.025	CbGeAlD
Olanzapine—HTR1D—connective tissue—Graves' disease	0.00232	0.0241	CbGeAlD
Olanzapine—H1F0—pituitary gland—Graves' disease	0.00231	0.024	CbGeAlD
Olanzapine—H1F0—adipose tissue—Graves' disease	0.0023	0.0239	CbGeAlD
Olanzapine—H1F0—thyroid gland—Graves' disease	0.00199	0.0207	CbGeAlD
Olanzapine—HTR7—connective tissue—Graves' disease	0.00185	0.0192	CbGeAlD
Olanzapine—DRD2—eye—Graves' disease	0.00182	0.0189	CbGeAlD
Olanzapine—HTR2B—adipose tissue—Graves' disease	0.00166	0.0172	CbGeAlD
Olanzapine—CHRM3—adipose tissue—Graves' disease	0.00149	0.0155	CbGeAlD
Olanzapine—HTR2B—thyroid gland—Graves' disease	0.00144	0.0149	CbGeAlD
Olanzapine—HRH1—eye—Graves' disease	0.00143	0.0149	CbGeAlD
Olanzapine—HRH1—connective tissue—Graves' disease	0.00138	0.0143	CbGeAlD
Olanzapine—ADRA1A—adipose tissue—Graves' disease	0.00137	0.0142	CbGeAlD
Olanzapine—ADRA2A—connective tissue—Graves' disease	0.00136	0.0141	CbGeAlD
Olanzapine—DRD2—pituitary gland—Graves' disease	0.00135	0.014	CbGeAlD
Olanzapine—ADRA2C—pituitary gland—Graves' disease	0.00131	0.0136	CbGeAlD
Olanzapine—ADRA2C—adipose tissue—Graves' disease	0.00131	0.0135	CbGeAlD
Olanzapine—CHRM3—thyroid gland—Graves' disease	0.00129	0.0134	CbGeAlD
Olanzapine—HTR2A—eye—Graves' disease	0.0012	0.0124	CbGeAlD
Olanzapine—HTR2A—connective tissue—Graves' disease	0.00115	0.012	CbGeAlD
Olanzapine—HRH1—adipose tissue—Graves' disease	0.00106	0.011	CbGeAlD
Olanzapine—ADRA2A—pituitary gland—Graves' disease	0.00105	0.0109	CbGeAlD
Olanzapine—ADRA2A—adipose tissue—Graves' disease	0.00104	0.0108	CbGeAlD
Olanzapine—CYP1A2—thyroid gland—Graves' disease	0.00098	0.0102	CbGeAlD
Olanzapine—ADRA2A—thyroid gland—Graves' disease	0.000901	0.00936	CbGeAlD
Olanzapine—HTR2A—pituitary gland—Graves' disease	0.000889	0.00923	CbGeAlD
Olanzapine—ABCB1—pituitary gland—Graves' disease	0.000583	0.00605	CbGeAlD
Olanzapine—ABCB1—adipose tissue—Graves' disease	0.00058	0.00602	CbGeAlD
Olanzapine—ABCB1—thyroid gland—Graves' disease	0.000502	0.00521	CbGeAlD
Olanzapine—HRH4—Signaling by GPCR—IL2RA—Graves' disease	9.85e-05	0.000883	CbGpPWpGaD
Olanzapine—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	9.85e-05	0.000883	CbGpPWpGaD
Olanzapine—DRD2—GPCR ligand binding—CXCL10—Graves' disease	9.71e-05	0.00087	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	9.67e-05	0.000867	CbGpPWpGaD
Olanzapine—CHRM2—SIDS Susceptibility Pathways—IL1B—Graves' disease	9.67e-05	0.000867	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	9.63e-05	0.000863	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—TSHR—Graves' disease	9.62e-05	0.000863	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—GC—Graves' disease	9.56e-05	0.000857	CbGpPWpGaD
Olanzapine—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	9.55e-05	0.000856	CbGpPWpGaD
Olanzapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	9.54e-05	0.000855	CbGpPWpGaD
Olanzapine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	9.54e-05	0.000855	CbGpPWpGaD
Olanzapine—HRH1—GPCR ligand binding—CXCL10—Graves' disease	9.53e-05	0.000855	CbGpPWpGaD
Olanzapine—CHRM1—GPCR ligand binding—CXCL10—Graves' disease	9.5e-05	0.000852	CbGpPWpGaD
Olanzapine—CHRM3—GPCR ligand binding—CXCL10—Graves' disease	9.47e-05	0.000849	CbGpPWpGaD
Olanzapine—HTR1E—GPCR downstream signaling—IL2RA—Graves' disease	9.45e-05	0.000847	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—IL2RA—Graves' disease	9.38e-05	0.000841	CbGpPWpGaD
Olanzapine—CHRM2—GPCR ligand binding—CXCL10—Graves' disease	9.38e-05	0.000841	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—TSHR—Graves' disease	9.36e-05	0.000839	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR ligand binding—CXCL10—Graves' disease	9.35e-05	0.000839	CbGpPWpGaD
Olanzapine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	9.34e-05	0.000837	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—TSHR—Graves' disease	9.21e-05	0.000826	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—TSHR—Graves' disease	9.14e-05	0.000819	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—TSHR—Graves' disease	9.1e-05	0.000816	CbGpPWpGaD
Olanzapine—ALB—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	9.1e-05	0.000815	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—TSHR—Graves' disease	9.08e-05	0.000814	CbGpPWpGaD
Olanzapine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	9.01e-05	0.000807	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—TSHR—Graves' disease	8.78e-05	0.000787	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—TSHR—Graves' disease	8.74e-05	0.000783	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	8.69e-05	0.000779	CbGpPWpGaD
Olanzapine—HTR1E—Signaling by GPCR—IL2RA—Graves' disease	8.58e-05	0.000769	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—TSHR—Graves' disease	8.5e-05	0.000762	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—TSHR—Graves' disease	8.49e-05	0.000761	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—GC—Graves' disease	8.46e-05	0.000759	CbGpPWpGaD
Olanzapine—HTR6—GPCR downstream signaling—CXCL10—Graves' disease	8.44e-05	0.000757	CbGpPWpGaD
Olanzapine—HTR7—GPCR downstream signaling—CXCL10—Graves' disease	8.43e-05	0.000756	CbGpPWpGaD
Olanzapine—HRH2—GPCR downstream signaling—IL2RA—Graves' disease	8.41e-05	0.000754	CbGpPWpGaD
Olanzapine—HTR1D—GPCR downstream signaling—CXCL10—Graves' disease	8.38e-05	0.000751	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—TSHR—Graves' disease	8.36e-05	0.00075	CbGpPWpGaD
Olanzapine—DRD5—GPCR downstream signaling—IL2RA—Graves' disease	8.36e-05	0.000749	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	8.36e-05	0.000749	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—TSHR—Graves' disease	8.34e-05	0.000747	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—TSHR—Graves' disease	8.31e-05	0.000745	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—TSHR—Graves' disease	8.28e-05	0.000743	CbGpPWpGaD
Olanzapine—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	8.27e-05	0.000742	CbGpPWpGaD
Olanzapine—HTR1B—GPCR downstream signaling—CXCL10—Graves' disease	8.2e-05	0.000735	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—TSHR—Graves' disease	8.2e-05	0.000735	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—TSHR—Graves' disease	8.18e-05	0.000733	CbGpPWpGaD
Olanzapine—ALB—Selenium Micronutrient Network—TNF—Graves' disease	8.11e-05	0.000727	CbGpPWpGaD
Olanzapine—DRD4—GPCR downstream signaling—CXCL10—Graves' disease	8.07e-05	0.000724	CbGpPWpGaD
Olanzapine—CHRM4—GPCR downstream signaling—CXCL10—Graves' disease	7.96e-05	0.000714	CbGpPWpGaD
Olanzapine—ADRA2B—Hemostasis—IL2RA—Graves' disease	7.83e-05	0.000702	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—GC—Graves' disease	7.77e-05	0.000696	CbGpPWpGaD
Olanzapine—ABCB1—Allograft Rejection—TNF—Graves' disease	7.75e-05	0.000695	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—TSHR—Graves' disease	7.71e-05	0.000691	CbGpPWpGaD
Olanzapine—HTR2B—GPCR downstream signaling—CXCL10—Graves' disease	7.71e-05	0.000691	CbGpPWpGaD
Olanzapine—HTR6—Signaling by GPCR—CXCL10—Graves' disease	7.67e-05	0.000687	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—CXCL10—Graves' disease	7.66e-05	0.000687	CbGpPWpGaD
Olanzapine—HRH2—Signaling by GPCR—IL2RA—Graves' disease	7.64e-05	0.000685	CbGpPWpGaD
Olanzapine—CHRM5—GPCR downstream signaling—CXCL10—Graves' disease	7.63e-05	0.000684	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—CXCL10—Graves' disease	7.62e-05	0.000683	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—CXCL10—Graves' disease	7.61e-05	0.000682	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	7.6e-05	0.000681	CbGpPWpGaD
Olanzapine—DRD5—Signaling by GPCR—IL2RA—Graves' disease	7.59e-05	0.000681	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—TSHR—Graves' disease	7.59e-05	0.00068	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—TSHR—Graves' disease	7.57e-05	0.000679	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—TSHR—Graves' disease	7.55e-05	0.000677	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—TSHR—Graves' disease	7.52e-05	0.000674	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—CXCL10—Graves' disease	7.45e-05	0.000668	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—TSHR—Graves' disease	7.45e-05	0.000668	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—TSHR—Graves' disease	7.43e-05	0.000666	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—CXCL10—Graves' disease	7.33e-05	0.000657	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—IL2RA—Graves' disease	7.31e-05	0.000656	CbGpPWpGaD
Olanzapine—DRD1—GPCR downstream signaling—CXCL10—Graves' disease	7.27e-05	0.000652	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—B3GNT2—Graves' disease	7.25e-05	0.00065	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—CXCL10—Graves' disease	7.23e-05	0.000648	CbGpPWpGaD
Olanzapine—DRD3—GPCR downstream signaling—CXCL10—Graves' disease	7.17e-05	0.000643	CbGpPWpGaD
Olanzapine—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	7.15e-05	0.000641	CbGpPWpGaD
Olanzapine—CHRM2—SIDS Susceptibility Pathways—TNF—Graves' disease	7.02e-05	0.000629	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TSHR—Graves' disease	7.01e-05	0.000628	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TSHR—Graves' disease	7e-05	0.000628	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—CXCL10—Graves' disease	7e-05	0.000627	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TSHR—Graves' disease	6.96e-05	0.000624	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—CXCL10—Graves' disease	6.93e-05	0.000621	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	6.9e-05	0.000619	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TSHR—Graves' disease	6.81e-05	0.000611	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TSHR—Graves' disease	6.7e-05	0.000601	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—CXCL10—Graves' disease	6.63e-05	0.000594	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TSHR—Graves' disease	6.61e-05	0.000593	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—CXCL10—Graves' disease	6.6e-05	0.000592	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—CXCL10—Graves' disease	6.51e-05	0.000584	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—CXCL10—Graves' disease	6.47e-05	0.00058	CbGpPWpGaD
Olanzapine—HTR6—GPCR downstream signaling—IL2RA—Graves' disease	6.45e-05	0.000578	CbGpPWpGaD
Olanzapine—HTR7—GPCR downstream signaling—IL2RA—Graves' disease	6.45e-05	0.000578	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—B3GNT2—Graves' disease	6.41e-05	0.000575	CbGpPWpGaD
Olanzapine—HTR1D—GPCR downstream signaling—IL2RA—Graves' disease	6.4e-05	0.000574	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TSHR—Graves' disease	6.4e-05	0.000574	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TSHR—Graves' disease	6.33e-05	0.000568	CbGpPWpGaD
Olanzapine—HTR1B—GPCR downstream signaling—IL2RA—Graves' disease	6.27e-05	0.000562	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	6.25e-05	0.00056	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—CXCL10—Graves' disease	6.22e-05	0.000557	CbGpPWpGaD
Olanzapine—DRD4—GPCR downstream signaling—IL2RA—Graves' disease	6.17e-05	0.000553	CbGpPWpGaD
Olanzapine—ALB—Metabolism—GC—Graves' disease	6.13e-05	0.000549	CbGpPWpGaD
Olanzapine—CHRM4—GPCR downstream signaling—IL2RA—Graves' disease	6.09e-05	0.000546	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—CXCL10—Graves' disease	6.05e-05	0.000542	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TSHR—Graves' disease	6.03e-05	0.000541	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TSHR—Graves' disease	5.95e-05	0.000534	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—CXCL10—Graves' disease	5.95e-05	0.000534	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—IL2RA—Graves' disease	5.94e-05	0.000533	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—CXCL10—Graves' disease	5.91e-05	0.000529	CbGpPWpGaD
Olanzapine—HTR2B—GPCR downstream signaling—IL2RA—Graves' disease	5.89e-05	0.000528	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—B3GNT2—Graves' disease	5.89e-05	0.000528	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—CXCL10—Graves' disease	5.88e-05	0.000527	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—CXCL10—Graves' disease	5.87e-05	0.000526	CbGpPWpGaD
Olanzapine—HTR6—Signaling by GPCR—IL2RA—Graves' disease	5.86e-05	0.000525	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—IL2RA—Graves' disease	5.85e-05	0.000525	CbGpPWpGaD
Olanzapine—CHRM5—GPCR downstream signaling—IL2RA—Graves' disease	5.83e-05	0.000523	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—IL2RA—Graves' disease	5.82e-05	0.000522	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—IL2RA—Graves' disease	5.82e-05	0.000521	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—IL2RA—Graves' disease	5.69e-05	0.00051	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	5.68e-05	0.000509	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—CXCL10—Graves' disease	5.65e-05	0.000506	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—IL2RA—Graves' disease	5.6e-05	0.000502	CbGpPWpGaD
Olanzapine—DRD1—GPCR downstream signaling—IL2RA—Graves' disease	5.55e-05	0.000498	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—IL2RA—Graves' disease	5.53e-05	0.000496	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—GC—Graves' disease	5.5e-05	0.000493	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—CXCL10—Graves' disease	5.49e-05	0.000492	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	5.49e-05	0.000492	CbGpPWpGaD
Olanzapine—DRD3—GPCR downstream signaling—IL2RA—Graves' disease	5.48e-05	0.000491	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—CXCL10—Graves' disease	5.4e-05	0.000485	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	5.4e-05	0.000484	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—CXCL10—Graves' disease	5.39e-05	0.000483	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TSHR—Graves' disease	5.37e-05	0.000482	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—CXCL10—Graves' disease	5.37e-05	0.000481	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—GC—Graves' disease	5.37e-05	0.000481	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—CXCL10—Graves' disease	5.35e-05	0.00048	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—IL2RA—Graves' disease	5.35e-05	0.00048	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—CXCL10—Graves' disease	5.3e-05	0.000475	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—IL2RA—Graves' disease	5.29e-05	0.000475	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—CXCL10—Graves' disease	5.29e-05	0.000474	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TSHR—Graves' disease	5.19e-05	0.000465	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TSHR—Graves' disease	5.16e-05	0.000463	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—IL2RA—Graves' disease	5.07e-05	0.000454	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GC—Graves' disease	5.06e-05	0.000454	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—IL2RA—Graves' disease	5.04e-05	0.000452	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TSHR—Graves' disease	5.02e-05	0.00045	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GC—Graves' disease	5.02e-05	0.00045	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—CXCL10—Graves' disease	4.98e-05	0.000447	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—IL2RA—Graves' disease	4.98e-05	0.000446	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—IL2RA—Graves' disease	4.95e-05	0.000444	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TSHR—Graves' disease	4.94e-05	0.000443	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	4.91e-05	0.00044	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	4.9e-05	0.00044	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—CXCL10—Graves' disease	4.89e-05	0.000439	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—CXCL10—Graves' disease	4.88e-05	0.000437	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—CXCL10—Graves' disease	4.86e-05	0.000436	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—CXCL10—Graves' disease	4.81e-05	0.000432	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—CXCL10—Graves' disease	4.8e-05	0.00043	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	4.78e-05	0.000428	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—IL2RA—Graves' disease	4.75e-05	0.000426	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—IL2RA—Graves' disease	4.69e-05	0.00042	CbGpPWpGaD
Olanzapine—ALB—Metabolism—B3GNT2—Graves' disease	4.64e-05	0.000416	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—IL2RA—Graves' disease	4.62e-05	0.000414	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TSHR—Graves' disease	4.56e-05	0.000408	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—IL2RA—Graves' disease	4.55e-05	0.000408	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—CXCL10—Graves' disease	4.53e-05	0.000406	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—CXCL10—Graves' disease	4.52e-05	0.000406	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—IL2RA—Graves' disease	4.51e-05	0.000405	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—CXCL10—Graves' disease	4.49e-05	0.000403	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—IL2RA—Graves' disease	4.49e-05	0.000403	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—IL2RA—Graves' disease	4.48e-05	0.000402	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TSHR—Graves' disease	4.48e-05	0.000402	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TSHR—Graves' disease	4.47e-05	0.000401	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	4.46e-05	0.0004	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TSHR—Graves' disease	4.46e-05	0.0004	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TSHR—Graves' disease	4.44e-05	0.000398	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—CXCL10—Graves' disease	4.4e-05	0.000395	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TSHR—Graves' disease	4.4e-05	0.000395	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TSHR—Graves' disease	4.39e-05	0.000393	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	4.34e-05	0.000389	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—CXCL10—Graves' disease	4.33e-05	0.000388	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—IL2RA—Graves' disease	4.32e-05	0.000387	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GC—Graves' disease	4.29e-05	0.000384	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—CXCL10—Graves' disease	4.27e-05	0.000383	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—IL2RA—Graves' disease	4.2e-05	0.000376	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	4.19e-05	0.000376	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—B3GNT2—Graves' disease	4.17e-05	0.000374	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CXCL10—Graves' disease	4.13e-05	0.000371	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—IL2RA—Graves' disease	4.13e-05	0.00037	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	4.13e-05	0.00037	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—IL2RA—Graves' disease	4.12e-05	0.000369	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—IL2RA—Graves' disease	4.1e-05	0.000368	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CXCL10—Graves' disease	4.09e-05	0.000367	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—IL2RA—Graves' disease	4.09e-05	0.000367	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TSHR—Graves' disease	4.08e-05	0.000366	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—B3GNT2—Graves' disease	4.07e-05	0.000365	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—IL2RA—Graves' disease	4.05e-05	0.000363	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—IL2RA—Graves' disease	4.04e-05	0.000362	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CXCL10—Graves' disease	3.9e-05	0.00035	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CXCL10—Graves' disease	3.85e-05	0.000345	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—B3GNT2—Graves' disease	3.84e-05	0.000344	CbGpPWpGaD
Olanzapine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	3.82e-05	0.000343	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—IL2RA—Graves' disease	3.81e-05	0.000341	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—B3GNT2—Graves' disease	3.8e-05	0.000341	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	3.75e-05	0.000337	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	3.75e-05	0.000336	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—IL2RA—Graves' disease	3.74e-05	0.000335	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—IL2RA—Graves' disease	3.73e-05	0.000334	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—IL2RA—Graves' disease	3.72e-05	0.000333	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—IL2RA—Graves' disease	3.68e-05	0.00033	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—IL2RA—Graves' disease	3.67e-05	0.000329	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CXCL10—Graves' disease	3.47e-05	0.000311	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—IL2RA—Graves' disease	3.46e-05	0.00031	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—IL2RA—Graves' disease	3.46e-05	0.00031	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IL2RA—Graves' disease	3.44e-05	0.000308	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	3.41e-05	0.000306	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL2RA—Graves' disease	3.36e-05	0.000302	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CXCL10—Graves' disease	3.35e-05	0.000301	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CXCL10—Graves' disease	3.34e-05	0.000299	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL2RA—Graves' disease	3.31e-05	0.000297	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GC—Graves' disease	3.31e-05	0.000297	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL2RA—Graves' disease	3.27e-05	0.000293	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—B3GNT2—Graves' disease	3.25e-05	0.000291	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CXCL10—Graves' disease	3.24e-05	0.000291	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CXCL10—Graves' disease	3.19e-05	0.000286	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL2RA—Graves' disease	3.16e-05	0.000283	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL2RA—Graves' disease	3.13e-05	0.00028	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL2RA—Graves' disease	2.98e-05	0.000267	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CXCL10—Graves' disease	2.94e-05	0.000264	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL2RA—Graves' disease	2.94e-05	0.000264	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CXCL10—Graves' disease	2.9e-05	0.00026	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CXCL10—Graves' disease	2.89e-05	0.000259	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CXCL10—Graves' disease	2.88e-05	0.000258	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CXCL10—Graves' disease	2.87e-05	0.000257	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CXCL10—Graves' disease	2.84e-05	0.000255	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CXCL10—Graves' disease	2.84e-05	0.000254	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL2RA—Graves' disease	2.65e-05	0.000238	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	2.64e-05	0.000236	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL2RA—Graves' disease	2.56e-05	0.00023	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL2RA—Graves' disease	2.55e-05	0.000229	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—B3GNT2—Graves' disease	2.51e-05	0.000225	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL2RA—Graves' disease	2.48e-05	0.000222	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL2RA—Graves' disease	2.44e-05	0.000219	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL2RA—Graves' disease	2.25e-05	0.000202	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL2RA—Graves' disease	2.21e-05	0.000198	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL2RA—Graves' disease	2.21e-05	0.000198	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL2RA—Graves' disease	2.2e-05	0.000197	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL2RA—Graves' disease	2.19e-05	0.000197	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL2RA—Graves' disease	2.17e-05	0.000195	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL2RA—Graves' disease	2.17e-05	0.000194	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	2.01e-05	0.000181	CbGpPWpGaD
